BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Drug Development

  TG Therapeutics, Inc. Release: Data From Phase 2 Clinical Trial Of TG-1101 (Ublituximab) And Ibrutinib Shows Compelling Clinical Activity In Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)

  December 9, 2014

   · 

  9 min read
• RedHill Biopharma Ltd. Submits BEKINDA™ (RHB-102) European Marketing Authorization Application For Oncology Support

  December 9, 2014

   · 

  9 min read
• Business

  Calithera Biosciences, Inc. Gains Exclusive, Worldwide License To Mars Symbioscience’s Arginase Inhibitors

  December 9, 2014

   · 

  4 min read
• Drug Development

  Seattle Genetics, Inc. Presents Data From Novel Antibody-Drug Conjugate SGN-CD33A At American Society of Hematology Annual Meeting

  December 9, 2014

   · 

  8 min read
• Drug Development

  Calithera Biosciences, Inc. Presents Preclinical Study Findings For CB-839 At The 56th American Society of Hematology Annual Meeting

  December 9, 2014

   · 

  4 min read
• Drug Development

  Karyopharm Therapeutics Presents Positive Combination Data For Selinexor (KPT-330) In Multiple Myeloma Patients At American Society of Hematology 2014 Annual Meeting

  December 9, 2014

   · 

  9 min read
• Drug Development

  Sunesis Pharmaceuticals, Inc. Announces Presentation Of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial Of Vosaroxin In AML And High-Risk MDS At American Society of Hematology Annual Meeting

  December 9, 2014

   · 

  7 min read
• Drug Development

  Karyopharm Therapeutics Presents Positive Clinical Data For Selinexor (KPT-330) In NHL Patients At American Society of Hematology 2014 Annual Meeting

  December 9, 2014

   · 

  9 min read
• Drug Development

  Celgene Release: Additional Analyses Of High-Risk Patients From Phase 3 Study (AML-001) OF Vidaza® (Azacitidine For Injection) In Acute Myeloid Leukemia Presented At American Society of Hematology

  December 9, 2014

   · 

  7 min read
• BioCapital

  PCORI Board Approves Providing Up To $50 Million For CER On Hepatitis C

  December 9, 2014

   · 

  3 min read